Skip to content
healthcare.dev

MARGENZA

NDC 70720-022, margetuximab-cmkb, injection, solution, concentrate, from TerSera Therapeutics LLC.

Product NDC
70720-022
Status
Listed
Labeler
TerSera Therapeutics LLC
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761150
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70720-022 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MARGETUXIMAB25 mg/mL

Pharmacologic classes

HER2/Neu/cerbB2 Antagonists [MoA]; HER2/neu Receptor Antagonist [EPC]

Package NDCNDC-11Package

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6a6d50c7-06ea-479c-83cc-f197a9e428c9

Use it

Look up 70720-022 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70720-022 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70720-022. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.